Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.25
Bid: 11.50
Ask: 13.00
Change: 0.00 (0.00%)
Spread: 1.50 (13.043%)
Open: 12.25
High: 12.25
Low: 12.25
Prev. Close: 12.25
SNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Licence agreement with Proton Technologies Canada

1 Feb 2022 14:43

RNS Number : 3626A
Sabien Technology Group PLC
01 February 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.

1 February 2022

 

Sabien Technology Group plc

("Sabien" or the "Company" or the "Licensee")

 

Update on Licence agreement with Proton Technologies Canada Inc.

The Board of Sabien Technology Group plc (AIM:SNT), a Company focused on a Green Aggregation Strategy, announces today that it has signed a Licence Agreement (the "Agreement") with Proton Technologies Canada Inc., ("Proton" or the "Licensor") in relation to a hydrogen processing licence within UK territories and an option over the construction and operation of a City Oil Field ("COF") facility located on Proton's site in Saskatchewan, Canada. This follows on from the signed Heads of Terms announced on 11 November 2021.

The key elements of the Agreement are:

1. Proton grants to Sabien a non-transferable, non-exclusive license to use and exploit any and all of Proton's Technology Rights, for producing up to 20 tonnes of hydrogen per day in total, within the onshore areas of the United Kingdom (Great Britain and Northern Ireland) and the offshore areas within United Kingdom Territorial Waters for the purpose of making hydrogen and sequestering carbon using the processes provided for within the Proton's patents and intellectual property (the "License"). The Licence is non-transferable except to majority owned or controlled subsidiaries of the Licensee or in all other cases by written unanimous consent of the directors of the Licensor. Quantities of hydrogen to be recorded by Sabien and reported to Proton on a monthly basis.

2. Proton hereby grants an option to install an initial 24 tonnes per day, and up to 120 tonnes/day COF recycling plant (the "Facility") on the Licensor's site in Saskatchewan, Canada (the "Site"), the Facility is to be developed and operated through a special purpose vehicle, in which it is anticipated that Sabien will hold a minority equity position (the "SPV"), the SPV is to be externally funded. The parties acknowledge and agree that:

· installation of the Facility at the Site is subject to regulatory approval (environmental and planning), which will be applied for when commercially expedient;

· subject to receiving such approvals, the parties shall enter into an agreement (the "Facility License"). Subject to contract, the parties have agreed in principle that, under the terms of the Facility License, the SPV will pay to Proton a royalty on the same basis as the hydrogen royalty set out in the Agreement, based on the oil produced or consumed by the Facility;

· Sabien may appoint third party contractors to install the Facility at the Site on terms to be agreed between Sabien, Proton, and such third party; and

· the rights granted to the Sabien are at the option of the Licensee. In the event that the Approvals are not granted (or are subject to conditions not commercially viable to Sabien) then Sabien is not obliged to install the Facility at the Site.

 

3. Proton to provide all necessary technical assistance to validate suitable sites and to provide advice on establishing and operating the installation.

 

4. Consideration of £100,000 in cash. The royalty payable to Proton is US$0.05 per kg or H2 extracted and 2% of the value of any CO2 derived, offsetable against the cash consideration already paid, with minimum royalty payments of US$25,000 per annum from year 5; and

 

5. 280,000 warrants to be issued with exercise price of 60 pence per ordinary share of 3 pence each with an expiry date of 19 February 2023. The quantum of warrants was agreed as if the £100,000 cash consideration was paid in shares on a 1:1 basis at a share price of 35.7p.

 

Commenting on the Proton licence deal, Richard Parris, Executive Chairman, said:

"Sabien is delivering on its strategy of building a portfolio of operations which, in combination, provide critical elements of the transition to a Green Economy. Following Sabien's initial investment in Proton announced 14 October 2021, the Board is pleased to have now concluded this significant licence deal with Proton. This Agreement provides Sabien with an entry into the UK hydrogen market, secures a North American commercial entry for Sabien and helps to cement our relationship with City Oil Field of Korea".

Further Information:

Sabien Technology Group plc

Richard Parris, Executive Chairman

 

+44 20 7993 3700

 

Allenby Capital Limited (Nominated Adviser)

John Depasquale / Nick Harriss

 

+44 203 328 5656

Peterhouse Capital Limited (Broker)

Duncan Vasey / Lucy Williams

+44 207 469 0930

 

The person who arranged for the release of this announcement on behalf of the Company was Richard Parris, Executive Chairman.

A copy of this announcement will be available from the Company's website at www.sabien-tech.com

Further information on Proton Technologies Canada Inc., can be viewed at Lowest cost Hydrogen with Zero Emissions. (proton.energy)

A copy of the JS Global Advisory report is available on the Company's website at  https://sabien.com/wp-content/uploads/2021/11/Clear-Hydrogen-in-UK-.pdf

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRBSGDDGSGDGDB
Date   Source Headline
7th Jul 20217:00 amRNSTrading Update
25th Jun 202111:15 amRNSOperational Update
18th Jun 20217:00 amRNSAppointment of Chief Scientific Officer
22nd Apr 20214:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20214:36 pmRNSPrice Monitoring Extension
31st Mar 20215:00 pmRNSTotal Voting Rights
29th Mar 20213:45 pmRNSResult of AGM
25th Mar 20217:00 amRNSHalf-year Report
19th Mar 20218:45 amRNSHolding(s) in Company
11th Mar 20214:57 pmRNSHolding(s) in Company
10th Mar 20217:00 amRNSCorporate Update - US Subsidiary Established
8th Mar 202110:59 amRNSCorporate Update - Contract win
5th Mar 202112:32 pmRNSNotice of Annual General Meeting
5th Mar 20217:00 amRNSAppointment of Chief Financial Officer
3rd Mar 20214:33 pmRNSHolding(s) in Company
3rd Mar 202110:00 amRNSHolding(s) in Company
1st Mar 20215:06 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSHolding(s) in Company
26th Feb 20215:00 pmRNSTotal Voting Rights
26th Feb 202110:47 amRNSSignificant investment in emerging technology
24th Feb 20212:10 pmRNSHolding(s) in Company
24th Feb 202112:16 pmRNSHolding(s) in Company
23rd Feb 20213:45 pmRNSChange of Registered Office
22nd Feb 202110:35 amRNSResult of General Meeting and Total Voting Rights
12th Feb 20217:00 amRNSHolding(s) in Company
11th Feb 202111:03 amRNSHolding(s) in Company
10th Feb 202111:38 amRNSHolding(s) in Company
3rd Feb 20214:11 pmRNSPlacing and Notice of General Meeting
1st Feb 20217:00 amRNSAppointment of Non-Executive Director
28th Jan 20214:32 pmRNSHolding(s) in Company
28th Jan 20218:14 amRNSHolding(s) in Company
27th Jan 20211:28 pmRNSChange of Substantial Shareholding
27th Jan 20211:26 pmRNSHolding(s) in Company
25th Jan 20217:00 amRNSBoard Changes
20th Jan 20217:30 amRNSRestoration - Sabien Technology Group PLC
20th Jan 20217:00 amRNSWithdrawal from acquisition and other matters
12th Jan 20215:38 pmRNSFrequently asked questions regarding the GM
5th Jan 20217:00 amRNSPosting of Circular and Notice of General Meeting
21st Dec 20205:23 pmRNSHolding(s) in Company
21st Dec 20205:20 pmRNSHolding(s) in Company
2nd Dec 20205:14 pmRNSPosting of Annual Report and Accounts
19th Nov 20207:00 amRNSFinal Results & Update on Proposed Acquisition
5th Nov 20207:00 amRNSChange of Registered Office
2nd Nov 20207:00 amRNSUpdate on Acquisition
14th Sep 20203:30 pmRNSCorporate Update - Contract win
27th Jul 20207:00 amRNSChange of Adviser
27th Jul 20207:00 amRNSUpdate re. Suspension
6th Jul 20207:00 amRNSTrading Update
29th May 202011:15 amRNSManagement Change, Furlough Update
31st Mar 20207:00 amRNSSabien furloughs staff in response to C19 lockdown

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.